MedTrace Logo

Elevated Serum HDL in Four Generations of a Nashville Family

NCT00525109 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2017-03-20

No results posted yet for this study

Summary

The purpose of this study is to determine the genetic basis of one family's hereditary hyper-HDL-emia using multiple modalities such as linkage analysis and gene array.

Conditions

  • Hyperlipidemias

Interventions

OTHER

No Intervention

No intervention

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Douglas E Vaughan, MD · Vanderbilt University Medical Center

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2006-06-30
Completion
2006-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00525109 on ClinicalTrials.gov